In case you missed it, Katie Couric has a great story on Ed Damiano.
Enjoy!
Enjoy!
September 19, 2014
September 16, 2014
OmniPool? TidePod?
Congratulations to both, either and the combination. From the post on Tidepool's site:
Insulet is pleased to announce we are opening our data protocol to Tidepool to enable OmniPod users to upload their insulin pump and integrated blood glucose meter data to the Tidepool platform and future Tidepool applications. With the announcement from Dexcom regarding their agreement with Tidepool in August, users of both OmniPod insulin pumps and Dexcom continuous glucose monitors will see their data from both devices in one place in future Tidepool applications. (more)
http://tidepool.org/2014/09/16/insulet-and-tidepool/
Insulet and Tidepool
Raul Oliva, Marketing Director at Insulet
Insulet is pleased to announce we are opening our data protocol to Tidepool to enable OmniPod users to upload their insulin pump and integrated blood glucose meter data to the Tidepool platform and future Tidepool applications. With the announcement from Dexcom regarding their agreement with Tidepool in August, users of both OmniPod insulin pumps and Dexcom continuous glucose monitors will see their data from both devices in one place in future Tidepool applications. (more)
September 3, 2014
From the News Wire: CE Mark for Abbott's New Glucose Monitoring System
From The Abbott Press Release
ABBOTT RECEIVES CE MARK FOR FREESTYLE® LIBRE, A REVOLUTIONARY GLUCOSE MONITORING SYSTEM FOR PEOPLE WITH DIABETES
ABBOTT PARK, Ill., Sept. 3, 2014 /PRNewswire/ -- Abbott (NYSE: ABT) today announced that it has received CE Mark (Conformite Europeenne) for its FreeStyle® Libre Flash Glucose Monitoring System, a revolutionary new glucose sensing technology for people with diabetes. The system eliminates the need for routine finger pricks1, reading glucose levels through a sensor that can be worn on the back of the upper arm for up to 14 days. In addition, no finger prick calibration is needed—a key differentiator from current continuous glucose monitoring systems. The system will be available in seven countries across Europein the coming weeks.
Abbott′s FreeStyle Libre System consists of a small, round sensor—approximately the size of a two Euro coin—worn on the back of the upper arm, which measures glucose every minute in interstitial fluid through a small (5mm long, 0.4mm wide) filament that is inserted just under the skin and held in place with a small adhesive pad. A reader is scanned over the sensor to get a glucose result painlessly in less than one second. Scanning can take place while the sensor is under clothing2, making testing more discreet and convenient. Each scan displays a real-time glucose result, a historical trend and the direction the glucose is heading. The reader holds up to 90 days of data, providing a historical snapshot of glucose levels over time. The FreeStyle Libre System software enables the data to be presented in a user-friendly, visual chart for both healthcare professionals and patients, driving a more productive discussion around treatment and any necessary modification.
"The FreeStyle Libre System fulfills a major need for people living with diabetes," said Robert Ford, senior vice president, Diabetes Care, Abbott. "Our customers told us that the pain, inconvenience and indiscretion of finger pricking were the key reasons they weren't managing their diabetes as well as they should. Addressing these concerns has guided the development of FreeStyle Libre – a transformational product designed to not only remove the pain of finger pricking but also seamlessly integrate into their daily lives."
The FreeStyle Libre System will be available in France, Germany, Italy, Netherlands, Spain, Sweden and United Kingdom in the coming weeks and will be available for purchase online through a website in each market.More including footnotes:
http://abbott.mediaroom.com/2014-09-03-Abbott-Receives-CE-Mark-for-FreeStyle-Libre-a-Revolutionary-Glucose-Monitoring-System-for-People-with-Diabetes